Journal of Cancer Therapy

Volume 7, Issue 3 (March 2016)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

Complications from Plaque versus Proton Beam Therapy for Choroidal Melanoma: A Qualitative Systematic Review

HTML  XML Download Download as PDF (Size: 352KB)  PP. 169-185  
DOI: 10.4236/jct.2016.73018    2,696 Downloads   4,735 Views  Citations

ABSTRACT

Plaque brachytherapy has been a mainstay of treatment for choroidal melanoma to achieve intraocular tumor control. The most common radioisotopes used for treating smaller sized tumors are Iodine-125 in North America and Ruthenium-106 in Europe. Proton beam radiotherapy is available at a few centers and may also be used to achieve local tumor control. Both plaque and proton beam therapy are known to be associated with a range of complications that may affect visual outcome and quality of life. These include radiation retinopathy, optic neuropathy, neovascular glaucoma and local treatment failure, requiring enucleation. While differences in the rates of these complications have not been well established in the literature for patients treated with plaque versus proton beam therapy for choroidal melanoma, certain geographic regions prefer one treatment modality over the other. The purpose of this qualitative systematic review was to compare and contrast reported complications that developed with plaque and proton beam therapy for the treatment of choroidal melanoma in studies published over a ten-year period. Reported rates suggest that patients with proton beam therapy had potentially higher rates of complications, including vision loss, enucleation, and neovascular glaucoma compared to those with plaque therapy. The rates of optic neuropathy, radiation retinopathy, and cataract formation were widely variable for the two treatment modalities and rates of metastasis and metastasis-free survival appeared similar with both treatments. The most common reported predictors of ocular complications following both types of therapy were tumor distance from the optic nerve, tumor thickness, and radiation dose, suggesting that inherent tumor characteristics play a role in visual prognosis.

Share and Cite:

Tseng, V. , Coleman, A. , Zhang, Z. and McCannel, T. (2016) Complications from Plaque versus Proton Beam Therapy for Choroidal Melanoma: A Qualitative Systematic Review. Journal of Cancer Therapy, 7, 169-185. doi: 10.4236/jct.2016.73018.

Cited by

[1] Ocular Complications of Radiotherapy in Uveal Melanoma
Cancers, 2023
[2] Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours
2021
[3] Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part II: treatment indications and complications
2021
[4] Optic disc dose reduction in ocular brachytherapy using 125I notched COMS plaques: A simulation study based on current clinical practice
2020
[5] Personalized treatment planning in eye brachytherapy for ocular melanoma: Dosimetric analysis on ophthalmic structure at risk
2020
[6] Investigation of optic disc dose reduction in ocular brachytherapy using 125I notched COMS plaques
2019
[7] A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using 125 I COMS plaques
2018
[8] A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using 125I COMS plaques
2018
[9] Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.
La Radiologia Medica, 2017
[10] 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity
Graefe's Archive for Clinical and Experimental Ophthalmology, 2016
[11] Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up
La radiologia medica, 2016
[12] Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma
American Journal of Ophthalmology, 2016

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.